Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

121.93
Delayed Data
As of May 21
 -10.04 / -7.61%
Today’s Change
13.09
Today|||52-Week Range
154.75
+32.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization673.0K662.0K156.0077.0K
 
 
 
 
 
 
Operating ExpensesGross Income-673.0K-662.0K-156.00-77.0K
 
 
 
 
 
General Expenses83.3M66.9M25.0M31.8M
 
 
 
 
 
Research And Development68.2M54.2M15.9M24.4M
 
 
 
 
 
Total Operating Expenses84.0M67.6M25.0M31.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-84.0M-67.6M-25.0M-31.9M
 
 
 
 
 
Extraordinary Charge--0.00-242.0K-176.0K
 
 
 
Interest Expense On Debt2.2M1.1M1.2M0.00
 
 
 
 
Other Expenses0.000.000.00350.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-86.2M-68.7M-26.4M-31.2M
 
 
 
 
 
Net Income-86.2M-68.7M-26.4M-31.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.8M--5.2M12.2M
 
 
 
 
Shares To Calculate EPS Diluted2.8M--5.2M12.2M
 
 
 
 
 
Earnings Per ShareEPS-$30.45---$5.07-$2.54
 
 
 
 
EPS Diluted-$30.45---$5.07-$2.54